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Abstract
Objective: Routine ovarian cancer screening is ineffective; therefore, no professional 
organization recommends this screening in asymptomatic patients. However, many physicians 
have recommended screening, exposing patients to unnecessary risk. Little research exists on how 
nonprofessional experience with cancer influences physicians’ screening practices. This study 
examines the association between physicians’ nonprofessional experience with cancer and 
reported adherence to ovarian cancer screening guidelines.
Materials and Methods: A mail questionnaire with an annual examination vignette and 
questions about cancer screening recommendations was sent to a random sample of 3,200 U.S. 
family physicians, general internists, and obstetrician-gynecologists. This analysis included 497 
physicians who received a vignette of a woman at average ovarian cancer risk and weighted results 
to represent these physician groups nationally. The outcome measure was adherence to ovarian 
cancer screening guidelines. Stepwise multivariate logistic regression estimated adjusted risk 
ratios for guideline adherence.
Results: In unadjusted analyses, 86.0% of physicians without nonprofessional cancer experience 
reported adherence to ovarian cancer screening guidelines compared with 69.2% of physicians 
with their own history of cancer, or a family member or close friend/coworker with cancer (p = 
0.0045). In adjusted analyses, physicians with cancer themselves or in a family member or close 
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friend/coworker were 0.82 times less likely (CI: 0.73–0.92) to report adhering to ovarian cancer 
screening recommendations than those without nonprofessional cancer experience.
Conclusions: Despite recommendations to the contrary, many physicians reported 
recommending ovarian cancer screening in low-risk women. Physicians with nonprofessional 
cancer experience were more likely to report offering or ordering nonrecommended screening than 
physicians without this experience.
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Introduction
ROUTINE OVARIAN CANCER screening is not recommended for the general population.1–4 The 
United States Preventive Services Task Force (USPSTF) has assigned routine screening for 
ovarian cancer a “D” grade, which indicates that there is fair evidence that routine screening 
is ineffective, or that the harms outweigh benefits. This assessment is based on the low 
positive predictive value and high false positive rates of existing tests—transvaginal 
ultrasound (TVU) and cancer antigen 125 (CA125)—and the lack of evidence that screening 
with these tests has significantly improved morbidity or mortality from ovarian cancer.5,6 
Despite recommendations against screening, a sizable proportion of physicians have 
reported ordering or offering ovarian cancer screening to patients in the general population, 
and a third of physicians have reported that they believe in TVU or CA125 as an effective 
screening test.7
A substantial literature has examined the patient and physician demographic characteristics, 
as well as practice characteristics associated with cancer screening,8–13 but little research 
has examined the relationship between physicians’ nonprofessional experience with cancer, 
and their cancer screening and treatment practices. One study by Armstrong et al.14 
surveyed primary care physicians, and found that physicians with a family member with 
breast cancer are 2.5 times more likely than those without to prescribe tamoxifen for breast 
cancer prevention,14 suggesting that physicians’ nonprofessional experience with cancer can 
impact their practice patterns.
This study seeks to contribute to this literature by examining the association between 
physicians’ nonprofessional experience with cancer and their reported ovarian cancer 
screening practices. We hypothesized that physicians who had had cancer themselves or 
whose family members, close friends, or coworkers had had cancer would be more likely to 
report offering or ordering nonrecommended ovarian cancer screening than those without 
this nonprofessional cancer experience. Results from this study can increase physician 
awareness of and improve training about factors that may unintentionally influence their 
clinical practices.
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Materials and Methods
Women’s Healthcare Survey
This study conducted a cross-sectional survey of U.S. physicians providing primary care to 
women. The Women’s Healthcare Survey included a 12-page mail questionnaire that 
examined several aspects of women’s healthcare services, with special emphasis on ovarian 
cancer screening, diagnosis, and management. It included items about physician 
demographics, practice characteristics, and training. One question asked whether any 
immediate family members; extended family members, close friends, or coworkers; or the 
physician him or herself had been diagnosed with cancer. The questionnaire also included 
three clinical vignettes, one assessing provision of women’s preventive care services at a 
woman’s annual examination visit. Demographic characteristics of the woman were varied 
by age (35 or 51 years), race (African American or Caucasian), and insurance status 
(Medicaid or private). In addition, characteristics determining the woman’s ovarian cancer 
risk varied, including medical and family history (high risk: paternal grandmother had 
ovarian cancer, paternal first cousin had premenopausal breast cancer, woman had breast 
cancer at age 30; medium risk: mother had ovarian cancer at age 62; and low risk: mother 
had breast cancer at age 70). The questionnaire also varied whether the woman requested 
ovarian cancer screening (request—“She requests cancer screening, especially for ovarian 
cancer…,” no request—“She wants to be sure she is up to date on all appropriate cancer 
screening tests”). The different combinations of these factors resulted in 48 unique vignette 
versions. After presenting the vignette, physicians were asked how often they would offer or 
order specific tests and studies (almost never, sometimes, or almost always) for that patient 
at that visit.
Survey sample and administration
The study sample included 3,200 U.S. physicians under the age of 65 practicing in office- or 
hospital-based settings. We randomly sampled an equal number of physicians practicing in 
family medicine, general internal medicine, and obstetrics-gynecology from each of the lists 
of 72,241 family physicians, 77,007 general internists, and 28,929 obstetrician-
gynecologists in the August 2008 American Medical Association (AMA) Masterfile.
Of the 3,200 physicians in the original study sample, 200 participated in a pilot test of the 
questionnaire. The pilot test used a single questionnaire version to compare the response 
rates with a shorter 8-page and the full 12-page questionnaire. The shorter version omitted 
questions about physician risk taking and fear of malpractice, and included only two of three 
vignettes. The annual examination vignette and the variables used in this study were 
measured in both questionnaire versions. The pilot test found equivalent response rates to 
the shorter and full-length questionnaires; thus, the 12-page questionnaire was used in the 
final survey.
The 3,000 physicians in the final survey were randomized equally to the 48 vignette 
versions. The questionnaire was administered in fall 2008 using a modified Tailored Design 
Method, with 2-day priority mailings, a US$20 bill included in the initial mailing, a 
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reminder postcard sent halfway through the survey period, and a handwritten thank you/
encouragement note from the principal investigator with the second mailing.
Study sample development
Of the 3,200 questionnaires sent to physicians, we excluded 33 duplicates, 95 undeliverable 
questionnaires, 19 retired, disabled, or deceased respondents, and 11 not currently 
practicing, leaving 3,042 questionnaires. The survey’s overall response rate was 61.7% 
(1,878 questionnaires returned). An additional 304 were excluded (200 did not currently 
provide outpatient care to women, 71 did not currently work in outpatient primary care 
settings, 10 worked in a specialty other than the three of interest, and 23 were current 
residents or fellows). To provide nationally representative results, this final study sample 
(591 family physicians, 414 general internists, and 569 obstetrician-gynecologists) was 
weighted to the representative number of the three specialties practicing in the U.S. using 
data from the AMA Masterfile.
This study’s analysis includes data only from those 504 physicians in the final sample who 
were presented with an annual examination vignette of a woman at average risk of ovarian 
cancer (mother had breast cancer at age 70, lifetime risk, 1.5%). All professional 
organizations recommend against ovarian cancer screening in these women.1–4 After 
excluding the seven questionnaires missing our primary independent variable (physician 
experience with cancer) or outcome (screening recommendation), the total sample size for 
this analysis was 497.
Study variables
Independent variable of interest.—This study’s primary variable of interest is 
physician experience with cancer in a nonprofessional setting (none; self; immediate family 
member; extended family member, close friend, or coworker). Because of the small number 
of physicians with nonprofessional cancer experience, we created a dichotomous variable 
(any or no nonprofessional cancer experience).
Outcome variable.—The outcome measure was reported adherence to ovarian cancer 
screening guidelines, defined as almost never ordering or offering ovarian cancer screening 
tests (TVU or CA125) to an asymptomatic patient at average risk of ovarian cancer in the 
questionnaire vignette.
Covariates.—This study’s covariates included the patient characteristics that were varied 
in the annual examination vignette: age, race, insurance type, and ovarian cancer testing 
request. These characteristics have been associated with cancer screening recommendation 
and use in other studies.
Physician and practice characteristics that might predict ovarian cancer screening practices 
based on the Theory of Reasoned Action and the Theory of Planned Behavior15–17 were also 
included in this study: age; sex; years in practice; specialty; geographic location (urban, 
large rural, or small/isolated small rural area [based on Rural Urban Commuting Area 
(RUCA) codes linked by physician mailing ZIP code]18,19); census division; primary 
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practice setting (e.g., office practice, community health center); group/solo practice type; 
involvement in clinical teaching; average number of outpatients seen weekly; board 
certification; belief about the effectiveness of cancer screening tests; measures of attitude 
toward risk-taking and malpractice concern20,21; and whether the physician listed the 
USPSTF, the American College of Obstetrics and Gynecology (ACOG), the National 
Institutes of Health (NIH)/National Cancer Institute (NCI), or the American Cancer Society 
(ACS) within the top three organizations influencing his or her cancer screening 
recommendations.
Analysis
We first described the study sample characteristics, then compared physicians’ unadjusted 
rates of reported adherence to ovarian cancer screening recommendations overall and by 
patient, physician, and practice characteristics, using p ≤ 0.01 to denote statistical 
significance in the table due to multiple comparisons (two-sided test). We constructed a 
multivariate logistic regression model with reported adherence to ovarian cancer screening 
recommendations as the outcome variable and physician’s nonprofessional cancer 
experience as the independent variable of interest. This stepwise multivariate logistic 
regression analysis included all patient characteristics, and tested those physician and 
practice characteristics that were significantly associated with reported guideline adherence 
at the p ≤ 0.05 level (two-sided test) in the unadjusted analysis. The final model includes all 
patient characteristics (age, race, insurance status, and request for ovarian cancer testing), 
and those physician and practice characteristics that significantly improved the fit of the 
regression model and were significantly associated with the study outcome (reported belief 
in TVU or CA125 as effective for ovarian cancer screening, listed USPSTF among top three 
sources of cancer screening information). We tested those variables that were significantly 
associated with reported guideline adherence in the final regression model for significant 
interactions with physician nonprofessional cancer experience, and found none. We used 
SUDAAN 10.0 (RTI International, Research Triangle Park, NC) to account for the survey’s 
sampling strategy and to produce estimates that represented a national population of family 
physicians, general internists, and obstetrician-gynecologists. This study was approved by 
the University of Washington Human Subjects Division.
Results
The majority of physicians in our sample (Table 1) were male (58.5%), Caucasian (71.1%), 
and practicing in an urban location (82.0%). Most (82.1%) reported practicing in an office-
based setting or freestanding clinic. Because we adjusted our findings using weights to 
represent the practicing U.S. physician population, the weighted specialty distribution was 
43.2% family physicians, 38.5% general internists, and 18.3% obstetrician-gynecologists.
In unadjusted analyses, 69.2% of physicians with nonprofessional experience with cancer 
reported adhering to ovarian cancer screening recommendations compared with 86.0% of 
physicians without nonprofessional cancer experience (p = 0.0045) (Table 2). Physicians 
were more likely to report adhering to ovarian cancer screening guidelines for a patient who 
did not specifically request ovarian cancer screening (79.7%) than for a patient who 
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requested ovarian cancer screening (63.9%, p ≤ 0.001) (Table 3). Physicians in solo practice 
were significantly less likely to report adhering than physicians in group practice (57.4% and 
75.8%, respectively; p ≤ 0.001). Physicians who listed the USPSTF as one of the top three 
organizations influencing their cancer screening recommendations were significantly more 
likely to report adhering to ovarian cancer screening guidelines than those who did not 
(79.6% vs. 62.7%, p ≤ 0.001). Last, physicians who believed that either TVU or CA125 was 
a clinically effective screening test for ovarian cancer were less likely to report adhering to 
evidence-based recommendations against ovarian cancer screening than those who did not 
believe in these as effective screening tests (47.7% vs. 82.9%, p ≤ 0.001).
In adjusted analysis (Table 4), physicians’ nonprofessional cancer experience remained a 
strong predictor of reported adherence to recommendations against ovarian cancer screening
—physicians with nonprofessional cancer experience were 0.82 times less likely to report 
adhering to these recommendations than physicians without this experience (CI: 0.73–0.92). 
This analysis adjusted for patient age, race, insurance status, and request for ovarian cancer 
testing, and two physician characteristics—belief in TVU or CA125 as effective for ovarian 
cancer screening, and USPSTF listed among top three sources of cancer screening 
information. Other significant predictors of reported adherence to ovarian cancer screening 
recommendations included patient insurance (physicians presented with a privately insured 
vs. Medicaid-insured patient, RR 0.86 [CI: 0.78–0.96]), patient request for screening 
(physicians presented with a patient who requested screening vs. one who did not, RR 0.82 
[CI: 0.74–0.92]), belief in either TVU or CA125 as a clinically effective screening test for 
ovarian cancer (yes vs. no, RR 0.61 [CI: 0.51–0.73]), and listing the USPSTF as one of the 
top three organizations influencing their cancer screening recommendations (yes vs. no, RR 
1.15 [CI: 1.03–1.28]).
Discussion
Physicians with their own cancer or experience with cancer among family, close friends/
coworkers were significantly more likely to report recommending unwarranted screening for 
ovarian cancer than physicians without this experience. This suggests that physicians’ 
nonprofessional experiences, in this case with cancer, are associated with clinical practice 
patterns that can have potential detrimental impacts on patients. For example, ovarian cancer 
screening, with its high false positive and low positive predictive value, is known to result in 
unnecessary and costly surgeries and their complications.5,22
This study contributes to a scarce literature on the association between healthcare providers’ 
personal health experiences, or the health experiences of those close to them and their 
clinical practices. Armstrong et al.’s14 finding that primary care physicians with a family 
member with breast cancer are more likely to prescribe tamoxifen suggests that they may be 
more sensitized to women’s breast cancer risk, or more comfortable with their knowledge 
about breast) cancer prevention strategies like tamoxifen. Zerzan et al.’s qualitative 
interviews of primary care physicians, hospitalists, geriatricians, oncologists, and palliative 
care specialists suggest that physician opioid prescribing patterns are impacted by personal 
experiences, both positive and negative.23 Physicians reported being influenced to use both 
more opiates because of a relative who experienced severe pain at end of life and fewer 
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opiates because of a parent who was addicted to prescription medications. Finally, Faundes 
et al.’s analysis of a national survey of Brazilian obstetrician-gynecologists found that 
physicians who had personal experience with the emergency contraceptive pill (among 
women physicians or the partners of male physicians) reported greater willingness to 
provide information about the emergency contraceptive pill and to prescribe it. They24 also 
found that those physicians who had experienced an unwanted pregnancy and had had an 
abortion, either themselves or with their partner, reported greater willingness to help a 
woman obtain an abortion if she requested one.25
There is also evidence that physicians’ nonmedical beliefs influence their medical decisions. 
Ramondetta et al.26 analyzed survey results from 273 gynecologic oncologists to evaluate 
the association between their religious and spiritual beliefs and their clinical practice 
patterns. Nearly half of the physician respondents to this survey reported that their religious 
and spiritual beliefs play a role in their medical decisions. This was confirmed in a series of 
scenarios examining the association between religious and spiritual beliefs, and the 
treatments that the physicians offered theoretical patients.26
Further research is needed to understand why physicians with cancer experience outside the 
professional setting were more likely to report offering or ordering nonrecommended 
ovarian cancer screening. In the 1980s, Weinstein27 found that adults with medical illness 
experience believed that these conditions are more prevalent in the population, were more 
serious, and caused more worry than those without this experience. Adults with close friends 
or relatives with medical illness had similar beliefs but to a lesser degree.27 If physicians 
experienced similar responses to their nonprofessional cancer experience, this might result in 
both overestimation of patients’ cancer risk and greater emphasis on cancer prevention and 
screening. Analysis of physicians’ ability to accurately estimate cancer risk from the 
Women’s Health Survey suggests that physicians with a history of cancer may overestimate 
cancer risk, but the analysis was limited by low numbers of physician cancer survivors 
(unpublished data).
This study’s reliance on survey methods results in measures of self-reported practices, which 
may not reflect true practice. In addition, survey results reflect only respondents. This survey 
had a solid response rate of 62%, but we do not know if physicians with cancer experience 
were proportionately reflected in this sample. We do not have information on the types and 
severity of cancer (e.g., ovarian vs. other cancer types) that the physicians or their family, 
close friends, and coworkers experienced, nor did our survey question differentiate first-
degree relatives from others such as close friends and coworkers, all of which could have 
influenced the physicians’ reported screening practices. We also did not ask whether 
physicians had the capacity to provide TVU in their offices, which could influence their 
screening practices. Exploring factors such as these in a future study could help elucidate the 
reasons behind the association between physicians’ nonprofessional experience with cancer 
and nonrecommended ovarian cancer screening. Finally, since the time this survey was 
conducted, the USPSTF updated its recommendations, confirming its assignment of a “D” 
grade to routine screening for ovarian cancer,28 and the FDA released a Safety 
Communication recommending against using currently offered tests to screen for ovarian 
cancer.29 It is possible that differences in reported rates of ovarian cancer screening between 
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physicians with and without nonprofessional cancer experience may have changed in 
response to these recommendations. However, this does not change our study’s finding that 
physicians’ nonprofessional cancer experience has the potential to affect practice behavior.
Conclusion
Physicians’ nonprofessional experience with cancer was associated with their reported 
ovarian cancer screening practices. In this study, physicians with nonprofessional cancer 
experience reported higher rates of nonrecommended screening among low-risk women, 
which carries potential risk for these women. Given the important impacts that physicians’ 
nonprofessional cancer experiences can have on patient care, further work is needed to 
understand this unintended phenomenon, to increase medical providers’ awareness of these 
influences, and to develop strategies to ensure that these providers’ practices reflect 
evidence-based practices that are truly appropriate for their patients.
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Table 1.
DEMOGRAPHIC, PERSONAL, AND PRACTICE CHARACTERISTICS OF STUDY PHYSICIANS
Characteristics % n = 497
Nonprofessional cancer experience
 Self 4.0
 Family member, close friend, or coworker 80.3
 None 15.6
Age
 30–39 23.1
 40–49 34.6
 50–64 42.3
Race
 Caucasian 72.0
 Asian/Pacific Islander 16.2
 African American 4.9
 Other, including American Indian/Alaska 6.8
 Native, mixed race, and missing race
Hispanic ethnicity 4.5
Female sex 41.5
Primary specialty
 Family medicine 43.2
 General internal medicine 38.5
 Obstetrics-gynecology 18.3
Board certified 90.1
Years in practice
 0–10 18.7
 11–20 36.3
 21+ 45.0
Primary practice setting
 Office practice or freestanding clinic 82.0
 Urgicenter 1.8
 Hospital outpatient department 4.8
 Health maintenance organization or other prepaid practice 1.2
 Community health center, nonfederal government clinic, tribal health center/Indian Health Service 4.9
 Federal government-operated clinic 2.6
 Other, including institutional setting, family planning clinic 2.5
Practice type
 Solo practice 23.9
 Group practice 72.7
 Other 3.4
Weekly average number of patients
 1–60 28.2
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Ragland et al. Page 11
Characteristics % n = 497
 61–90 30.4
 91+ 41.5
Involved in clinical teaching 41.2
Geographic location
 Urban 82.0
 Large rural 9.6
 Small/remote rural 8.4
Census division
 New England 3.4
 Middle Atlantic 14.9
 East North Central 17.0
 West North Central 7.0
 South Atlantic 15.6
 East South Central 6.8
 West South Central 8.3
 Mountain 8.1
 Pacific 18.9
Level of risk taking
 Low (6–17) 59.0
 Medium (18–24) 34.0
 High (25+) 6.9
Fear of malpractice
 Low (2–4) 11.2
 Medium (5–7) 31.0
 High (8+) 57.8
Listed USPSTF among top three sources of cancer screening information 53.8
Listed NIH/NCI among top three sources of cancer screening information 34.9
Listed ACOG among top three sources of cancer screening information 32.2
Listed ACS among top three sources of cancer screening information 64.6
Reported believing TVU as clinically effective in screening for ovarian cancer 27.8
Reported believing CA125 as clinically effective in screening for ovarian cancer 18.6
Reported believing either TVU or CA125 as clinically effective in screening for ovarian cancer 31.4
Missing data—based on unweighted respondents: Race (11); Hispanic ethnicity (3); board certification (1); primary practice setting (3); weekly 
average number of patients (4); involved in clinical teaching (2); level of risk taking (8); fear of malpractice (6); believed TVU clinically effective 
in screening (10); believed CA125 clinically effective in screening (11); and believed TVU or CA125 clinically effective in screening (8).
Missing data for race are included in the “other” category.
Results were adjusted using weights to represent the specialty distribution of the practicing U.S. physician population of family physicians, general 
internists, and obstetrician-gynecologists.
ACOG, American College of Obstetricians and Gynecologists; ACS, American Cancer Society; CA125, cancer antigen 125; NCI, National Cancer 
Institute; NIH, National Institutes of Health; TVU, transvaginal ultrasound; USPSTF, United States Preventive Services Task Force.
J Womens Health (Larchmt). Author manuscript; available in PMC 2019 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Ragland et al. Page 12
Table 2.
UNADJUSTED RATE OF PHYSICIAN-REPORTED ADHERENCE TO RECOMMENDATIONS AGAINST OVARIAN CANCER SCREENING 
BY PHYSICIAN NONPROFESSIONAL CANCER EXPERIENCE
Physician nonprofessional cancer experience Rate of adherence to recommendations (%) (n = 497)
None (n = 73)a 86.0
Any experience (n = 424) 69.2
ap ≤ 0.01.
Results were adjusted using weights to represent the specialty distribution of the practicing U.S. physician population of family physicians, general 
internists, and obstetrician-gynecologists.
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Table 3.
UNADJUSTED RATE OF PHYSICIAN-REPORTED ADHERENCE TO RECOMMENDATIONS AGAINST OVARIAN CANCER SCREENING 
BY PATIENT, PHYSICIAN, and PRACTICE CHARACTERISTICS
All physicians (n = 497)
Total 71.8
Patient characteristics
 Age (years)
  35 72.4
  51 71.3
 Race
  African American 72.6
  Caucasian 70.1
 Insurance typea
  Private 67.8
  Medicaid 76.5
 Requested ovarian cancer screeningb
  Yes 63.9
  No 79.7
Physician and practice characteristics
 Age (years)
  30–39 78.7
  40–49 73.4
  50–64 66.7
 Sex
  Female 73.8
  Male 70.4
 Specialtyc
  Family medicine 72.8
  Obstetrics-gynecology 60.5
  General internal medicine 76.0
 Board certification
  Yes 73.1
  No 58.3
 Years in practice
  0–10 75.2
  11–20 72.7
  21+ 69.6
 Practice typeb
  Solo practice 57.4
  Group practice or other practice type 76.3
 Weekly average number of patients
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All physicians (n = 497)
  1–60 76.9
  61–90 75.6
  91+ 65.5
 Involved in clinical teaching
  Yes 72.9
  No 70.8
 Geographic location
  Small rural/remote rural 66.8
  Large rural 69.0
  Urban 72.6
 Census division
  New England 59.5
  Middle Atlantic 65.5
  East North Central 80.8
  West North Central 67.8
  South Atlantic 76.2
  East South Central 68.0
  West South Central 63.4
  Mountain 64.2
  Pacific 77.0
 Level of risk taking
  Low (6–17) 71.8
  Medium (18–24) 71.7
  High (25+) 71.8
 Fear of malpractice
  Low (2–4) 73.5
  Medium (5–7) 77.2
  High (8+) 68.8
 USPSTF among top three sources of cancer screening informationb
  Yes 79.6
  No 623
 NIH/NCI among top three sources of cancer screening informationa
  Yes 65.9
  No 75.0
 ACOG among top three sources of cancer screening information
  Yes 67.4
  No 73.9
 ACS among top three sources of cancer screening information
  Yes 70.6
  No 74.0
 TVU is clinically effective in screening for ovarian cancerb
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All physicians (n = 497)
  Agree 48.1
  Disagree 81.0
 CA125 is clinically effective in screening for ovarian cancerb
  Agree 40.2
  Disagree 79.3
 Either TVU or CA125 is clinically effective in screening for ovarian cancerb
  Agree 47.7
  Disagree 82.9
ap ≤ 0.05
bp ≤ 0.001
cp ≤ 0.01.
Results were adjusted using weights to represent the specialty distribution of the practicing U.S. physician population of family physicians, general 
internists, and obstetrician-gynecologists.
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Table 4.
RISK OF PHYSICIAN-REPORTED ADHERENCE TO RECOMMENDATIONS AGAINST OVARIAN CANCER SCREENING BY PATIENT 
AND PHYSICIAN CHARACTERISTICS, UNADJUSTED and ADJUSTED MODELSa
Unadjusted risk ratios (95% CI) Adjusted risk ratios (95% CI)
 Nonprofessional cancer experience
   None  (Ref.)  (Ref.)
   Any  0.80 (0.71–0.90)  0.82 (0.73–0.92)
 Patient characteristics
  Patient age
   35  (Ref.)  (Ref.)
   51  0.99 (0.88–1.11)  1.00 (0.90–1.11)
  Screening requested
   No  (Ref.)  (Ref.)
   Yes  0.80 (0.71–0.90)  0.82 (0.74–0.92)
  Patient race
   White  (Ref.)  (Ref.)
   Black  1.02 (0.91–1.15)  1.03 (0.93–1.15)
  Patient insurance
   Medicaid  (Ref.)  (Ref.)
   Private  0.89 (0.79–1.00)  0.86 (0.78–0.96)
 Physician characteristics
  Reported belief in TVU or CA125 as effective for ovarian cancer screening
   No  (Ref.)  (Ref.)
   Yes  0.58 (0.48–0.70)  0.61 (0.51–0.73)
  Listed USPSTF among top three sources of cancer screening information
   No  (Ref.)  (Ref.)
   Yes  1.27 (1.12–1.44)  1.15 (1.03–1.28)
Results were adjusted using weights to represent the specialty distribution of the practicing U.S. physician population of family physicians, general 
internists, and obstetrician-gynecologists.
aAdjusted model includes all variables in the table.
USPSTF, U.S. Preventive Services Task Force.
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